<DOC>
	<DOCNO>NCT02338505</DOCNO>
	<brief_summary>Phase II prospective single-institutional study .</brief_summary>
	<brief_title>Teleassisted Surgery Gynecological Disease Obese Patients - OB-ALFX</brief_title>
	<detailed_description>The aim Phase II prospective single-institutional study ass feasibility early complication rate Telelap ALF-X surgical treatment obese patient affect gynecological disease .</detailed_description>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Genital Diseases , Female</mesh_term>
	<criteria>inform consent 30 â‰¤ BMI &lt; 40 ASA &lt; III Ovarian Cyst Prophylactic bilateral salpingooophorectomy Ectopic Pregnancy Pelvic Inflammatory Disease Sterility/Infertility Benign uterine disease ( fibromatosis , adenomyosis ) Endometrial hiperplasia Earlystage Endometrial Cancer Preneoplastic lesion cervix IA1 Cervical Cancer Pelvic endometriosis Pregnancy Liver disease Coagulopathies Clinical condition contraindicate laparoscopy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Robotic Surgery</keyword>
	<keyword>Telelap-ALFX</keyword>
	<keyword>Gynecological disease</keyword>
</DOC>